Search

Author/Creator Clement, Paul M

1. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. Issue 6 (June 2021)

Authors:
van den Bent, Martin J; Tesileanu, C Mircea S; Wick, Wolfgang; Sanson, Marc; Brandes, Alba Ariela; Clement, Paul M; Erridge, Sarah; Vogelbaum, Michael A; Nowak, Anna K; Baurain, Jean Français; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Rogers, Leland; Taa...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 6(2021)
Page Start:
813
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial. Issue 5 (May 2015)

Authors:
Machiels, Jean-Pascal H; Haddad, Robert I; Fayette, Jérôme; Licitra, Lisa F; Tahara, Makoto; Vermorken, Jan B; Clement, Paul M; Gauler, Thomas; Cupissol, Didier; Grau, Juan José; Guigay, Joël; Caponigro, Francesco; de Castro, Gilberto; de Souza Viana, Luciano; Keilholz, Ulrich; del Campo, Joseph ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 5(2015:May)
Page Start:
583
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study. Issue 4 (13th July 2020)

Authors:
Rosenthal, Mark; Clement, Paul M; Campone, Mario; Gil-Gil, Miguel J; DeGroot, John; Chinot, Olivier; Idbaih, Ahmed; Gan, Hui; Raizer, Jeffrey; Wen, Patrick Yung; Pineda, Estela; Donnet, Valerie; Mills, David; El-Hashimy, Mona; Mason, Warren
Journal:
ESMO open
Issue:
Volume 5:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Issue 8 (1st July 2020)

Authors:
van den Bent, Martin; Eoli, Marica; Sepulveda, Juan Manuel; Smits, Marion; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul M; Chinot, Olivier; de Vos, Filip; Whenham, Nicolas; Sanghera, Paul; Weller, Michael; Dubbink, H J; French, Pim; Looman, Jim; Dey, Jyotirmoy; K...
Journal:
Neuro-oncology
Issue:
Volume 23:Issue 8(2021)
Page Start:
1415
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Detection of delirium in palliative care unit patients: A prospective descriptive study of the Delirium Observation Screening Scale administered by bedside nurses. (January 2014)

Authors:
Detroyer, Elke; Clement, Paul M; Baeten, Nele; Pennemans, Michèle; Decruyenaere, Marleen; Vandenberghe, Joris; Menten, Johan; Joosten, Etienne; Milisen, Koen
Journal:
Palliative medicine
Issue:
Volume 28:Number 1(2014)
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand. Issue 1 (9th December 2019)

Authors:
Hoogstrate, Youri; Vallentgoed, Wies; Kros, Johan M; de Heer, Iris; de Wit, Maurice; Eoli, Marica; Sepulveda, Juan Manuel; Walenkamp, Annemiek M E; Frenel, Jean-Sebastien; Franceschi, Enrico; Clement, Paul M; Weller, Micheal; van Royen, Martin E; Ansell, Peter; Looman, Jim; Bain, Earle; Morfouace...
Journal:
Neuro-oncology advances
Issue:
Volume 2:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Issue 5 (20th November 2019)

Authors:
Van Den Bent, Martin; Eoli, Marica; Sepulveda, Juan Manuel; Smits, Marion; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul M; Chinot, Olivier; De Vos, Filip; Whenham, Nicolas; Sanghera, Paul; Weller, Michael; Dubbink, H J; French, Pim; Looman, Jim; Dey, Jyotirmoy; K...
Journal:
Neuro-oncology
Issue:
Volume 22:Issue 5(2020)
Page Start:
684
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Issue 10103 (7th October 2017)

Authors:
van den Bent, Martin J; Baumert, Brigitta; Erridge, Sara C; Vogelbaum, Michael A; Nowak, Anna K; Sanson, Marc; Brandes, Alba Ariela; Clement, Paul M; Baurain, Jean Francais; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Brachman, David G; Taal, Walter; Rudà,...
Journal:
Lancet
Issue:
Volume 390:Issue 10103(2017)
Page Start:
1645
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Issue 9 (29th April 2021)

Authors:
Tesileanu, C Mircea S; van den Bent, Martin J; Sanson, Marc; Wick, Wolfgang; Brandes, Alba A; Clement, Paul M; Erridge, Sara C; Vogelbaum, Michael A; Nowak, Anna K; Baurain, Jean F; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Rogers, Leland; Taal, Walter; ...
Journal:
Neuro-oncology
Issue:
Volume 23:Issue 9(2021)
Page Start:
1547
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Issue 11 (November 2016)

Authors:
Baumert, Brigitta G; Hegi, Monika E; van den Bent, Martin J; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khê; Brandes, Alba A; Kantor, Guy; Taphoorn, Martin J B; Hassel, Mohamed Ben; Hartmann, Christian; Ryan, Gail; Capper, David; Kros, Johan M; Kurscheid, Sebastian; Wick, Wolfgang; Entin...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 11(2016:Nov.)
Page Start:
1521
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗